Cutter Capital Management »

Cabaletta Bio shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 230k 22.70

More positions owned by Cutter Capital Management

Amgen (AMGN)
Merck & Co (MRK)
Amicus Therapeutics (FOLD)
Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Roivant Sciences SHS (ROIV)
Exelixis (EXEL)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Royalty Pharma Shs Class A (RPRX)
ACADIA Pharmaceuticals (ACAD)
BioCryst Pharmaceuticals (BCRX)
Halozyme Therapeutics (HALO)
Perrigo SHS (PRGO)
Pfizer (PFE)
Bristol Myers Squibb (BMY)

View all positions for Cutter Capital Management

Top funds holding Cabaletta Bio

Jennison Associates
Fred Alger Management
VR Adviser
Vanguard Group
Lynx1 Capital Management
Deerfield Management Company
Perceptive Advisors
Holocene Advisors
Commodore Capital
Redmile Group
Wellington Management Company
T. Rowe Price Associates
Ikarian Capital
Victory Capital Management
Blackstone Group

View all funds holding Cabaletta Bio